Stock screenerAll disclosures →
EDGAR →
NATR
Conviction 32HealthcareScan · Thu, Jun 25, 2026Dragonfly doji
NATR$20.67-0.91%
ResistanceSupportVol 14Insider sellVol MA14 139.48K
Mar 26Apr 14May 1May 19Jun 8Jun 25
Price20.67
Change-0.91%
Gap-1.01%
Rel volume1.50×
Avg volume155.2K
Avg $ vol3.17M
SMA 2020.42
SMA 5023.00
SMA 20021.65
Price vs 50-10.14%
Price vs 200-4.54%
MA stackmixed
50/200 cross—
Supertrenddown · 22.35
RSI (14)42
MACD hist0.24
MACD cross—
Stoch %K / %D69 / 78
ADX (14)43
+DI / −DI14 / 20
RSI divergence—
MACD divergence—
ATR %+3.64%
ADR %3.38%
52w high27.80
52w low13.14
From 52w high-25.65%
Above 52w low+57.31%
New 52w highNo
SqueezeOff
Bollinger width10.43%
%B0.62
Donchian pos47.88%
Donchian high22.02
Donchian low19.43
AVWAP (52w high)23.24
vs AVWAP high-11.07%
AVWAP (52w low)22.80
vs AVWAP low-9.33%
OBV trendFlat
Chaikin MF (20)-0.12
Today vs 20d1.50×
Avg vol (14d)139.48K
Avg vol (20d)155.2K
Avg $ vol (20d)3.17M
Market cap363.48M
RS 3m (vs SPY)-24.68%
RS 6m (vs SPY)-13.94%
RS line new highNo
Trend template3/8
Technical rank28.8
1 week+2.94%
1 month-5.57%
3 months-13.04%
6 months-5.96%
1 year+36.89%
YTD-1.43%
P/E18.62
P/B2.66
P/S0.76
P/FCF12.60
EPS1.06
Div yield—
ROE14.29%
ROA7.47%
Debt/Eq0.00
Current2.50
EV/EBITDA7.15
Gross margin72.42%
Net margin4.07%
Rev growth5.67%
EPS growth153.65%
Price target—
Target upside—
Analyst rating—
Institutional—
Ent. value275.9M
Revenue122.89M
Net income5.12M
Gross profit89.98M
Free cash flow28.84M
IndustryPHARMACEUTICAL PREPARATIONS
ExchangeNasdaq
Shares out17.58M
Employees806
ListedThu, Aug 7, 1980
Free float14.44M
Float %82.1%
Short interest342.57K
Days to cover2.5d
Short volume68.8%
Squeeze score44 / 100
Next earningsThu, Jul 30, 2026 (35d)
EPS forecast—
Last EPS vs est—
Last surprise—
Setup gradeD
Conviction32 / 100
Pattern quality—
Tech rank28.8 / 100
Group rank50 / 100
Status lane—
Setup direction—
Pattern family
Resistance—
Support—
Days since event—
Candle confirmDragonfly doji
News sentiment—
Financials as of Tue, Mar 31, 2026 · quarterly.
Congress activity
Disclosed STOCK Act trades in NATR
No recent disclosed trades by Congress in NATR. STOCK Act filings can lag the trade by up to 45 days.
Insider activity
SEC Form 4 transactions in NATR · 8 buys · 2 sells
| Insider | Side | Shares | Value | Traded | Filed |
|---|---|---|---|---|---|
Norman Daniel C EVP & President, Asia · Common Shares · 2026-06-01 | Sell | 9.71K | $200K | 2026-06-01 | 2026-06-03 |
Brower Nathan G EVP, General Counsel · Common Shares · 2026-05-21 | Sell | 12.02K | $262K | 2026-05-21 | 2026-05-22 |
Fasching Steven J. Director · Common Shares · 2026-05-15 | Grant | 4.5K | $0 | 2026-05-15 | 2026-05-20 |
Yang Rong Director · Common Shares · 2026-05-15 | Grant | 4.5K | $0 | 2026-05-15 | 2026-05-19 |
Wissmiller Heidi Director · Common Shares · 2026-05-15 | Grant | 4.5K | $0 | 2026-05-15 | 2026-05-19 |
Straus Robert D Director · Common Shares · 2026-05-15 | Grant | 4.5K | $0 | 2026-05-15 | 2026-05-19 |
Brower Nathan G EVP, General Counsel · Common Shares · 2026-05-15 | Grant | 9K | $0 | 2026-05-15 | 2026-05-19 |
Norman Daniel C EVP & President, Asia · Common Shares · 2026-05-15 | Grant | 11.38K | $0 | 2026-05-15 | 2026-05-19 |
Fuller Kevin Gregory Global Chief Marketing Officer · Common Shares · 2026-05-15 | Grant | 8.98K | $0 | 2026-05-15 | 2026-05-19 |
Romanzi Kenneth G. Chief Executive Officer · Common Shares · 2026-05-15 | Grant | 33.75K | $0 | 2026-05-15 | 2026-05-19 |
SEC filings
EDGAR filings in NATR
No recent SEC filings on file for NATR.
Get daily signals & real-time alerts.
StockSetups scans ~12,300 US stocks & ETFs after every close and sorts every long setup into four ranked lanes — each with a trade plan — plus an always-on engine firing 35+ real-time intraday alerts. Free for 7 days, cancel in one click.
Start free — 7-day full access →Educational data, not financial advice. Patterns, levels and the trade plan are algorithmic, not a recommendation to trade.